|
Market Closed -
Nasdaq Stockholm
12:00:00 2026-08-21 EDT
|
5-day change | 1st Jan Change | ||
| 5.300 SEK | 0.00% |
|
+2.12% | +15.22% |
| 08-20 | Active Biotech AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 08-20 | Active Biotech reports reduced operating loss | FW |
Chart: Technical Analysis
Stock exchange
Nasdaq Stockholm
ACTI 5.300 kr
0.00%
97.23K
kr
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq Stockholm
| ACTI | 5.300SEK | 0.00% | 97.23K kr | |
Nasdaq Stockholm
| ACTI | 5.300SEK | 0.00% | 97.23K kr | |
|
CBOE
| ACTIs | 5.230SEK | -0.76% | 11.51K kr | |
|
Deutsche Boerse AG
| BTP | 0.4295EUR | +2.63% | 0 € | |
|
CBOE
| 0GQU | 190.00SEK | 0.00% | 0 kr | |
|
Börse Stuttgart
| BTP | 0.4560EUR | +0.22% | 0 € |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Neutral |
| Resistance | 5.5 | 8.08 | 13.52 |
| Spread/Res. | -3.64% | -34.41% | -60.80% |
| Spread/Supp. | +3.92% | +31.84% | +38.02% |
| Support | 5.1 | 4.02 | 3.84 |
- Stock Market
- Stocks
- ACTI Stock
- ACTI Stock
- Charts Active Biotech AB
Select your edition
All financial news and data tailored to specific country editions
